In particular, PD-L1 found on the surface of tumor-derived EVs promotes tumor progression and migration, contributes to the suppression of anti-tumor immune responses and mediates resistance to immunotherapies by binding directly to blocking antibodies [145]. Here, CD274 is linked to neoplasm.